Comparison of angiogenic markers with clinical parameters
| No (%) | MVD | VEGFR-2 | CD133 | All patients |
|---|---|---|---|---|
| AC, adenocarcinoma; MVD, microvessel density; SCC, squamous cell carcinoma; VEGFR-2 (KDR), vascular endothelial growth factor receptor 2. | ||||
| No. of positive cases | 29 | 30 | 43 | 63 |
| Diagnosis | ||||
| AC | 11 (38%) | 11 (37%) | 19 (44%) | 25 (40%) |
| SCC | 17 (59%) | 17 (57%) | 22 (51%) | 34 (54%) |
| Other | 1 (3%) | 2 (6%) | 2 (4%) | 4 (6%) |
| Stage | ||||
| Stage 1 | 17 (59%) | 20 (67%) | 30 (70%) | 42 (67%) |
| Stage 2 | 6 (21%) | 4 (13%) | 8 (19%) | 13 (21%) |
| Stage 3 | 6 (21%) | 4 (13%) | 5 (11%) | 8 (13%) |
| Died | 9 (31%) | 9 (40%) | 14 (33%) | 18 (29%) |